EPF's EU Elections campaign 2024


Towards a truly participatory, democratic, and impactful involvement of patient organisations

AI Knowledge Hub

Want to learn more about Artificial Intelligence in Healthcare?

Our AI Knowledge Hub will help patient organisations and other interested stakeholders to better engage in debates, projects and initiatives on Artificial Intelligence in Healthcare, both at a national and European level.

AMR INFO Point

Understanding Antimicrobial Resistance (AMR) and its impact on patients. The AMR Info Point is dedicated to providing extensive resources on AMR. Our goal is to improve awareness and understanding of AMR among patient communities.

Ukraine Crisis Resources Page

All Ukraine crisis related information from our Members

WHAT WE DO

Policy and advocacy, icon

Policy and advocacy

EPF is active in a number of policy areas to ensure that patients' views are incorporated into the EU policy agenda. We develop campaign and advocacy strategies

Projects icon

Projects

EPF has been active in various health-related EU projects over the past few years both as a leader or associate partner to gather patient-related evidence based information

Capacity building icon

Capacity building

The Capacity Building Programme was designed in 2012 to respond to needs and concerns which have been identified by our membership during previous activities of EPF.

NEWS AND UPDATES

24/07/24 EVENTS PATIENT EMPOWERMENT PATIENT INVOLVEMENT

Call for patients who have experienced Antimicrobial Resistance (AMR)

As part of the European Antibiotic Awareness Day on 18 November 2024, EPF is collaborating with the European Centre for Disease Prevention and Control (ECDC) and Health First Europe (HFE) to launch a new series of patient stories highlighting

24/07/24 EVENTS PATIENT EMPOWERMENT PATIENT INVOLVEMENT

EPF’s feedback on the Implementing Act on HTA cooperation with EMA

The European Patients' Forum (EPF) welcomes the publication of the European Commission's draft Implementing Act on Health Technology Assessment (HTA) in cooperation with the European Medicines Agency (EMA). We strongly support close interaction

28/06/24 EVENTS PATIENT EMPOWERMENT PATIENT INVOLVEMENT

EPF’s analysis of the European Parliament reports on the revision of the EU pharmaceutical legislation

On 10 April 2024, the European Parliament adopted the reports on the Directive and the Regulation, thus formalising the Parliament's official position on the revision of the EU pharmaceutical legislation. The reports of the European Parliament

Upcoming events

Interested in becoming a member?

As your advocate, EPF provides many benefits to its members. We represent our members' voice at the European level on cross-cutting health issues.

Our team